Search Results - "Cappellini, M.D."

5610611 REAL‐WORLD EVIDENCE CHARACTERIZING THE BURDEN OF DISEASE IN ALPHA AND BETA THALASSEMIA PATIENTS IN THE USA: AN INTERIM ANALYSIS by Musallam, K.M., Taher, A.T., Lombard, L., Gilroy, K., Lewis, K., Mellor, J., Golden, K., Cappellini, M.D.

Get full text

X-chromosomal inactivation directly influences the phenotypic manifestation of X-linked protoporphyria by Brancaleoni, V., Balwani, M., Granata, F., Graziadei, G., Missineo, P., Fiorentino, V., Fustinoni, S., Cappellini, M.D., Naik, H., Desnick, R.J., Di Pierro, E.

“…X‐linked protoporphyria (XLP), a rare erythropoietic porphyria, results from terminal exon gain‐of‐function mutations in the ALAS2 gene causing increased ALAS2…”
Get full text

Deferasirox (Exjade) for the treatment of iron overload by Cappellini, M D, Taher, A

“…Deferasirox is a once-daily oral iron chelator with established dose-dependent efficacy in both adult and pediatric patients with transfusional iron overload…”
Get more information

I09 Thalassemia syndromes by Cappellini, M.D

Get full text

S05 Chelation therapy in transfusional iron overload: Exjade efficacy and safety by Cappellini, M.D

Get full text

Transcranial colour /INS;Doppler in adult patients with sickle cell disease by Casoni, F.M, Graziadei, G, Marcon, A, Ridolfi, P, Gandolfi, I, Annoni, F, Cappellini, M.D

Get full text

Clostridium difficile infection epidemiology and management: Comparison of results of a prospective study with a retrospective one in a reference teaching and research hospital in Northern Italy by Domeniconi, G., MD, Serafino, S., MD, Migone De Amicis, M., MD, Formica, S., MD, Lanzoni, M., MSc, PhD, Maraschini, A., MD, Sisto, F., MD, Consonni, D., MD, MPH, PhD, Cappellini, M.D., MD, Fabio, G., MD, Castaldi, S., MD

“…Highlights • Time spent on training may reflect attitude to follow adopted protocols. • Training is the most important factor to support new practices. • It…”
Get full text

P1035 LIVER (LS) AND SPLEEN STIFFNESS (SS) IN PATIENTS WITH HAEMOGLOBINOPATHIES. DATA FROM TRANSIENT ELASTOGRAPHY (TE) by Conti, C.B, Giunta, M, Fraquelli, M, Zanaboni, L, Graziadei, G, Terrani, C, D'Ambrosio, R, Cassinerio, E, Colombo, M, Cappellini, M.D, Conte, D

Get full text

Thalassemic osteopathy: A new marker of bone deposition by Baldini, M., Forti, S., Orsatti, A., Marcon, A., Ulivieri, F.M., Airaghi, L., Zanaboni, L., Cappellini, M.D.

“…Osteopathy represents a prominent cause of morbidity in patients with beta-thalassemia major (TM) and manifests as osteopenia/osteoporosis. Biochemical…”
Get full text

Home infusion program with enzyme replacement therapy for Fabry disease: The experience of a large Italian collaborative group by Concolino, D., Amico, L., Cappellini, M.D., Cassinerio, E., Conti, M., Donati, M.A., Falvo, F., Fiumara, A., Maccarone, M., Manna, R., Matucci, A., Musumeci, M.B., Nicoletti, A., Nisticò, R., Papadia, F., Parini, R., Peluso, D., Pensabene, L., Pisani, A., Pistone, G., Rigoldi, M., Romani, I., Tenuta, M., Torti, G., Veroux, M., Zachara, E.

“…Fabry disease (FD) [OMIM 301500] is an X-linked lysosomal storage disorder caused by a deficiency of the lysosomal enzyme alpha-galactosidase A, resulting in…”
Get full text

Peg-interferon and ribavirin therapy is safe and effective among HCV patients with thalassaemia major by D’Ambrosio, R, Poggiali, E, Mazzoleni, M, Aghemo, A, Lai, M.E, Cianciulli, P, Colombo, M, Cappellini, M.D

Get full text

Regular erytrocytapheresis programme in adults with liver complications in sickle cell disease by Torretta, L, Mocellin, M.C, Usardi, P, Villa, M.A, Manera, M.C, Graziadei, G, Cappellini, M.D

Get full text

P-183 Gastrointestinal disturbances in iron-overloaded myelodysplastic syndromes patients receiving concomitant medications during deferasirox treatment by Gattermann, N, Porter, J.B, Rose, C, Schmid, M, Vassilieff, D, Guerci-Bresler, A, Ganser, A, Taylor, K, Louw, V.J, El-Ali, A, Martin, N, Cappellini, M.D

Get full text

P.18.16 HEPATIC AND SPLENIC STIFFNESS MEASURED BY TRANSIENT ELASTOGRAPHY: FEASIBILITY AND POSSIBLE ROLE IN PATIENTS WITH HEMOGLOBINOPATHIES by Conti, C.B, Fraquelli, M, Zanaboni, L, Giunta, M, Graziadei, G, Branchi, F, Terrani, C, Cassinerio, E, Colombo, M, Cappellini, M.D, Conte, D

Get full text

P.16.16 HEPCIDIN IS A PIVOTAL MEDIATOR OF INFLIXIMAB-INDUCED IMPROVEMENT OF IRON METABOLISM IN INFLAMMATORY BOWEL DISEASES by Cavallaro, F, Pastorelli, L, Duca, L, Rigolini, R, Munizio, N, Spina, L, Tontini, G.E, Costa, E, Cappellini, M.D, Vecchi, M

Get full text

Liver fibrosis in adult thalassemia patients assessed by transient elastography by Fraquelli, M, Cassinerio, E, Volpato, E, Rigamonti, C, Cappellini, M.D, Conte, D, Colombo, M

Get full text

LIVER AND HEART IRON OVERLOAD EXTIMATED BY T2 MAGNETIC RESONANCE (MRI T2) IN PATIENTS WITH THALASSEMIA INTERMEDIA (TI) by Fasulo, M.R, Cappellini, M.D, Cesaretti, C, Cassinerio, E, Proto, P, Pedrotti, P, Pedretti, S, Dellegrottaglie, S, Roghi, A

Get full text

594 ERYTHROID DIFFERENTIATION IS SUPPRESSED BY RIBAVIRIN DURING COMBINATION THERAPY WITH PEGYLATED INTERFERON-α2a IN CHRONIC HEPATITIS C: AN IN VITRO AND IN VIVO STUDY by Aghemo, A, Ronzoni, L, Rumi, M.G, Prati, G.M, Monico, S, Colancecco, A, Grillo, P, Viganó, M, Cappellini, M.D, Colombo, M

Get full text

Metabolic reprogramming and mitochondrial dysfunction in HepG2 cells as potential drivers of AIP pathophysiology by Longo, M., Meroni, M., Paolini, E., Cappellini, M.D., Motta, I., Fracanzani, A.L., Di Pierro, E., Dongiovanni, P.

Get full text

LEFT ATRIAL SIZE AND FUNCTION ASSESSMENT BY CARDIAC MAGNETIC RESONANCE IN THALASSEMIA MAJOR PATIENTS WITH DIFFERENT IRON OVERLOAD CONDITIONS by Torlasco, C., Mollica, C., Cassinerio, E., Ruffino, E., Milazzo, A., Quattrocchi, G., Sormani, P., Abdel-Gadir, A., Giannattasio, C., Parati, G., Cappellini, M.D., Moon, J.C., Pedrotti, P.

Get full text